1. Home
  2. DEC vs AKBA Comparison

DEC vs AKBA Comparison

Compare DEC & AKBA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DEC
  • AKBA
  • Stock Information
  • Founded
  • DEC 2001
  • AKBA 2007
  • Country
  • DEC United States
  • AKBA United States
  • Employees
  • DEC N/A
  • AKBA N/A
  • Industry
  • DEC
  • AKBA Biotechnology: Pharmaceutical Preparations
  • Sector
  • DEC
  • AKBA Health Care
  • Exchange
  • DEC Nasdaq
  • AKBA Nasdaq
  • Market Cap
  • DEC 849.3M
  • AKBA 958.6M
  • IPO Year
  • DEC N/A
  • AKBA 2014
  • Fundamental
  • Price
  • DEC $14.90
  • AKBA $3.56
  • Analyst Decision
  • DEC Strong Buy
  • AKBA Strong Buy
  • Analyst Count
  • DEC 4
  • AKBA 5
  • Target Price
  • DEC $20.75
  • AKBA $6.90
  • AVG Volume (30 Days)
  • DEC 417.3K
  • AKBA 3.5M
  • Earning Date
  • DEC 01-01-0001
  • AKBA 08-07-2025
  • Dividend Yield
  • DEC 5.46%
  • AKBA N/A
  • EPS Growth
  • DEC N/A
  • AKBA N/A
  • EPS
  • DEC N/A
  • AKBA N/A
  • Revenue
  • DEC $758,798,000.00
  • AKBA $184,909,000.00
  • Revenue This Year
  • DEC $46.42
  • AKBA $26.88
  • Revenue Next Year
  • DEC $9.54
  • AKBA $44.34
  • P/E Ratio
  • DEC N/A
  • AKBA N/A
  • Revenue Growth
  • DEC N/A
  • AKBA N/A
  • 52 Week Low
  • DEC $10.08
  • AKBA $1.07
  • 52 Week High
  • DEC $17.70
  • AKBA $4.08
  • Technical
  • Relative Strength Index (RSI)
  • DEC 56.77
  • AKBA 43.13
  • Support Level
  • DEC $14.71
  • AKBA $3.77
  • Resistance Level
  • DEC $15.15
  • AKBA $4.04
  • Average True Range (ATR)
  • DEC 0.32
  • AKBA 0.17
  • MACD
  • DEC 0.01
  • AKBA -0.04
  • Stochastic Oscillator
  • DEC 75.38
  • AKBA 8.27

About DEC Diversified Energy Company plc

Diversified Energy Co PLC is an independent energy company focused on natural gas and liquids production, transportation, marketing, and well retirement, predominantly located within the Appalachian and Central regions of the United States. The company acquires and manages gas and oil properties and certain associated midstream assets. Its operations are located throughout the neighboring states of Tennessee, Kentucky, Virginia, West Virginia, Ohio, Pennsylvania, Oklahoma, Texas, and Louisiana. The company has one reportable segment that produces and transports natural gas, natural gas liquids (NGLs), and oil in the United States.

About AKBA Akebia Therapeutics Inc.

Akebia Therapeutics Inc is a fully integrated biopharmaceutical company. The Company's operating segment is the business of developing and commercializing novel therapeutics for people with kidney disease. The current portfolio of the company includes Auryxia (ferric citrate), a medicine approved and marketed in the United States for the control of serum phosphorus levels in adult patients with dialysis-dependent chronic kidney disease and the treatment of iron deficiency anemia, in adult patients with non-dialysis-dependent chronic kidney disease, Vafseo (vadadustat), an oral hypoxia-inducible factor prolyl hydroxylase, inhibitor approved in Japan for the treatment of anemia due to chronic kidney disease, in adult patients, HIF-PH inhibitors in preclinical development.

Share on Social Networks: